Immediate and chronic effects of AV-delay optimization in patients with cardiac resynchronization therapy

被引:43
|
作者
Hardt, Stefan E. [1 ]
Yazdi, Said Hashem Fani [1 ]
Bauer, Alexander [1 ]
Filusch, Arthur [1 ]
Korosoglou, Grigorlos [1 ]
Hansen, Alexander [1 ]
Bekeredjian, Raffi [1 ]
Ehlermann, Philipp [1 ]
Remppis, Andrew [1 ]
Katus, Hugo A. [1 ]
Kuecherer, Helmut F. [1 ]
机构
[1] Heidelberg Univ, Dept Cardiol, D-69120 Heidelberg, Germany
关键词
cardiac resynchronization; heart failure; echocardiography;
D O I
10.1016/j.ijcard.2006.03.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Acute changes of the AV-delay in CRT patients have a significant impact on hemodynamics. However, the chronic functional effects of AV-delay optimization have not been systematically examined despite of their potential role for chronic functional improvement. Methods: Therefore, in this study we investigated whether optimization of AV-delay in CRT patients as assessed by echocardiographic measurement of the velocity time integral of the left ventricular outflow tract (LVOT-VTI) chronically changes (1) echocardiographic parameters of systolic and diastolic left ventricular function, (2) walking distance in the 6-min walk test, (3) levels of NT-proBNP and (4) quality of life as assessed by a standard questionnaire, 3 3 patients underwent optimization of AV-delay 3 1 8 weeks after initiation of CRT. Follow up (FU) was conducted 43 5 days later. Results: E/Ea, the ratio of peak E-wave of mitral inflow and of TDI of the mitral annulus, significantly decreased immediately post-optimization (11 +/- 1 vs. 14 +/- 1 at baseline, p < 0.05) and further decreased at FU (8 +/- 1, p < 0.05 vs. immediately post-optimization) indicating improvement of diastolic function, while traditional parameters of diastolic function derived from pulse wave Doppler remained unchanged. There was a slight increase of LV-ejection fraction as assessed by echocardiography acutely after optimization (baseline: 25 +/- 2%, optimized: 28 +/- 1%, p < 0.05), while LV-ejection fraction at FU did not differ from baseline. 6-min walk test improved from 449 +/- 17 m (baseline) to 475 +/- 17 m at FU (p < 0.05). During this period NT-proBNP significantly decreased from 3193 +/- 765 ng/l to 2593 +/- 675 ng/l (p < 0.05). Quality of life was unchanged at FU. Conclusion: This study demonstrates for the first time chronic functional improvement due to AV-delay optimization in patients with CRT. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:318 / 325
页数:8
相关论文
共 50 条
  • [21] Is nominal AV delay offset optimal for heart failure patients receiving cardiac resynchronization therapy?
    Leman, R
    Gold, M
    Niazi, I
    Giudici, M
    Yu, YH
    Arcot-Krishnamurthy, S
    Strakna, J
    Hoyhtya, A
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (06) : S134 - S134
  • [22] Atropine and bicycle exercise effects on the optimal AV delay in cardiac resynchronization
    Belalcazar, Andres
    Butter, Christian
    Stellbrink, Christoph
    Sinha, Anil
    Cuesta, Francisca
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S61 - S61
  • [23] Interventricular Delay Optimization in Cardiac Resynchronization Therapy Devices
    Lebedeva, Viktoria
    Liubimtceva, Tamara
    Trukshina, Maria
    Lebedev, Dmitriy
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 : 79 - 80
  • [24] IEGM based method for estimating optimal AV delay in cardiac resynchronization therapy
    Meine, M
    Min, XY
    Kordmann, M
    Park, E
    Bruhns, K
    Levine, P
    Trappe, HJ
    JOURNAL OF CARDIAC FAILURE, 2004, 10 (04) : S74 - S74
  • [25] Longer Left Ventricular Electric Delay Reduces Mitral Regurgitation After Cardiac Resynchronization Therapy Mechanistic Insights From the SMART-AV Study (SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy)
    Chatterjee, Neal A.
    Gold, Michael R.
    Waggoner, Alan D.
    Picard, Michael H.
    Stein, Kenneth M.
    Yu, Yinghong
    Meyer, Timothy E.
    Wold, Nicholas
    Ellenbogen, Kenneth A.
    Singh, Jagmeet P.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2016, 9 (11):
  • [26] Cardiac resynchronization therapy is certainly cardiac therapy, but how much resynchronization and how much atrioventricular delay optimization?
    Kyriacou, Andreas
    Pabari, Punam A.
    Francis, Darrel P.
    HEART FAILURE REVIEWS, 2012, 17 (06) : 727 - 736
  • [27] Echocardiogram-guided optimal AV delay compared to invasively-guided optimal AV delay in CHF patients receiving cardiac resynchronization therapy
    Lieberman, R
    EUROPEAN HEART JOURNAL, 2001, 22 : 682 - 682
  • [28] Cardiac resynchronization therapy is certainly cardiac therapy, but how much resynchronization and how much atrioventricular delay optimization?
    Andreas Kyriacou
    Punam A. Pabari
    Darrel P. Francis
    Heart Failure Reviews, 2012, 17 : 727 - 736
  • [29] Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization
    Ziacchi, Matteo
    Diemberger, Igor
    Biffi, Mauro
    Martignani, Cristian
    Bertini, Matteo
    Rocchi, Guido
    Biagini, Elena
    Graziosi, Maddalena
    Mazzotti, Andrea
    Rapezzi, Claudio
    Boriani, Giuseppe
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2016, 17 (04) : 299 - 305
  • [30] Atrioventricular and interventricular delay optimization by echocardiography in cardiac resynchronization therapy
    Sugimoto, T.
    Hamaguchi, M.
    Ishiyama, M.
    Moriwaki, K.
    Horiguchi, M.
    Takamura, T.
    Sakabe, S.
    Seko, T.
    Bettou, K.
    Kasai, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 45 - 45